Back to Search Start Over

A multicentre study to determine the in vitro efficacy of flomoxef against extended-spectrum beta-lactamase producing Escherichia coli in Malaysia.

Authors :
Yap PSX
Chong CW
Ponnampalavanar S
Ramli R
Harun A
Tengku Jamaluddin TZM
Ahmed Khan A
Ngoi ST
Lee YQ
Lau MY
Tan SC
Kong ZX
Woon JJ
Mak ST
Abdul Jabar K
Karunakaran R
Ismail Z
Salleh SA
Md Noor SS
Masri SN
Mohd Taib N
Jasni AS
Tee LH
Leong KC
Lim VKE
Abu Bakar S
Teh CSJ
Source :
PeerJ [PeerJ] 2023 Nov 28; Vol. 11, pp. e16393. Date of Electronic Publication: 2023 Nov 28 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: The high burden of extended-spectrum beta-lactamase-producing (ESBL)-producing Enterobacterales worldwide, especially in the densely populated South East Asia poses a significant threat to the global transmission of antibiotic resistance. Molecular surveillance of ESBL-producing pathogens in this region is vital for understanding the local epidemiology, informing treatment choices, and addressing the regional and global implications of antibiotic resistance.<br />Methods: Therefore, an inventory surveillance of the ESBL- Escherichia coli (ESBL-EC) isolates responsible for infections in Malaysian hospitals was conducted. Additionally, the in vitro efficacy of flomoxef and other established antibiotics against ESBL-EC was evaluated.<br />Results: A total of 127 non-repetitive ESBL-EC strains isolated from clinical samples were collected during a multicentre study performed in five representative Malaysian hospitals. Of all the isolates, 33.9% were isolated from surgical site infections and 85.8% were hospital-acquired infections. High rates of resistance to cefotaxime (100%), cefepime (100%), aztreonam (100%) and trimethoprim-sulfamethoxazole (100%) were observed based on the broth microdilution test. Carbapenems remained the most effective antibiotics against the ESBL-EC, followed by flomoxef. Antibiotic resistance genes were identified by PCR. The bla <subscript>CTX-M-1</subscript> was the most prevalent ESBL gene, with 28 isolates (22%) harbouring bla <subscript>CTX-M-1</subscript> only, 27 isolates (21.3%) co-harbouring bla <subscript>CTX-M-1</subscript> and bla <subscript>TEM</subscript> , and ten isolates (7.9%) co-harbouring bla <subscript>CTX-M-1,</subscript> bla <subscript>TEM</subscript> and bla <subscript>SHV</subscript> . A generalised linear model showed significant antibacterial activity of imipenem against different types of infection. Besides carbapenems, this study also demonstrated a satisfactory antibacterial activity of flomoxef (81.9%) on ESBL-EC, regardless of the types of ESBL genes.<br />Competing Interests: Cindy Shuan Ju Teh is an Academic Editor for PeerJ. Loong Hua Tee and Kin Chong Leong were employed by Shionogi Singapore Pte Ltd at the time of the study.<br /> (© 2023 Yap et al.)

Details

Language :
English
ISSN :
2167-8359
Volume :
11
Database :
MEDLINE
Journal :
PeerJ
Publication Type :
Academic Journal
Accession number :
38047021
Full Text :
https://doi.org/10.7717/peerj.16393